Colorcon said that the addition of the film coating products from this acquisition complement its existing range of one-step, tablet film coatings for pharmaceutical solid oral dose development.
Jean-Claude Deneuville, president of Colorcon, said: “We are excited about this opportunity to expand our film coating offering. The acquisition broadens and strengthens our ability to respond to the specific needs of companies in the fast growing Asia/Pacific region.
“We will ensure the same high quality level of expertise, technical service, production and logistics support for these products that our customers have come to expect from Colorcon.”
Colorcon said that its core businesses include film coatings, modified release technologies, functional excipients and tablet design services. It has 17 technical service laboratories globally and more than 1100 employees exclusively dedicated to its pharmaceutical customer base.